Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![uniQure N.V. Graphic](https://lunarcrush.com/gi/w:26/t:$qure.png) uniQure N.V. (QURE)

uniQure N.V. (QURE) sees a surge in social media engagement, driven by positive clinical trial results and analyst recommendations. The stock is up XXX% in the last XX days.

### About uniQure N.V.
uniQure N.V. (QURE) is a biotechnology company focused on gene therapy for the treatment of severe diseases.  
uniQure N.V. uses the ticker $QURE for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$qure/insights)
- uniQure N.V. (QURE) social dominance hit XXXXX which is XXX% higher than it's daily average.
- uniQure N.V. (QURE) social dominance is up XXXXXXXX% from the previous week.
- uniQure N.V. (QURE) galaxy scoreβ„’ is up XXXXX% from the previous week.

### Price: $XX [#](/topic/$qure/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$qure/time-series/close.tsv)  
The price action is likely driven by a combination of positive sentiment from recent clinical trial data, analyst recommendations, and overall market enthusiasm for gene therapy stocks. The stock has seen a significant increase over the last XX days, and the recent public offering and the potential for future partnerships are also contributing factors.  

| 24-Hour | 7-Day  | 30-Day  |
| ------- | -----  | ------  |
| -XXXX%  | -XXXX% | XXXXXX% |

**1-Year High**: $XXXXX on 2025-10-09  
**1-Year Low**: $XXXX on 2024-11-04  
  
  
### AltRank: undefined [#](/topic/$qure/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$qure/time-series/alt_rank.tsv)  
uniQure N.V. (QURE) is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: undefined  
**1 Week**: XXX +251  
**1-Year High**: undefined on 2025-10-18  
**1-Year Low**: undefined on 2025-10-18  
  
  
### Galaxy Score: XXXXX [#](/topic/$qure/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$qure/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +17  
**1-Year High**: XX on 2025-10-12  
**1-Year Low**: XX on 2025-10-16  
  
  
### Engagements: XXXXXX [#](/topic/$qure/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$qure/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXXXX +1,209%  
**1-Year High**: XXXXXXXXX on 2025-09-24  
**1-Year Low**: XXXXX on 2025-07-13  

| Social Network | X      | TikTok | YouTube |
| -------------- | -      | ------ | ------- |
| Engagements    | XXXXXX | X      | X       |
  

  
  
### Mentions: XXX [#](/topic/$qure/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$qure/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX +229%  
**1-Year High**: XXXXX on 2025-09-25  
**1-Year Low**: XX on 2025-09-14  

| Social Network | X   | TikTok | YouTube |
| -------------- | -   | ------ | ------- |
| Mentions       | XXX | X      | X       |
  

  
  
### Creators: XXX [#](/topic/$qure/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$qure/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning uniQure N.V. (QURE) in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +256%  
**1-Year High**: XXXXX on 2025-09-25  
**1-Year Low**: XX on 2025-09-14  

The most influential creators that mention uniQure N.V. in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXX       |
| [@seedy19tron](/creator/twitter/seedy19tron)         | X    | XXXXX     | X     | XXXXX       |
| [@NoseRubInvest](/creator/twitter/NoseRubInvest)     | X    | XXXXX     | X     | XXXXX       |
| [@crux_capital_](/creator/twitter/crux_capital_)     | X    | XXXXX     | X     | XXXXX       |
| [@pawcio2009](/creator/twitter/pawcio2009)           | X    | XXXXXX    | X     | XXXXX       |
| [@HenryHarris666](/creator/twitter/HenryHarris666)   | X    | XXXXX     | X     | XXX         |
| [@mike98572986](/creator/twitter/mike98572986)       | X    | XXX       | X     | XXX         |
| [@DesertDweller93](/creator/twitter/DesertDweller93) | X    | XXXXX     | XX    | XXX         |
| [@Biobeats99](/creator/twitter/Biobeats99)           | X    | XXX       | XX    | XXX         |
| [@BostonDrei](/creator/twitter/BostonDrei)           | XX   | XXXXX     | X     | XXX         |

[View More](/list/creators/$qure/100)
  
  
### Sentiment: XX% [#](/topic/$qure/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$qure/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +13%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-15  

**Most Supportive Themes**
- **Positive Sentiment and Price Momentum:** (45%) Many posts express positive sentiment towards uniQure N.V. (QURE), with users highlighting recent price gains and potential for future growth.
- **Analyst Recommendations and Price Targets:** (20%) Several posts reference analyst ratings and price targets, with some suggesting that the current valuation is undervalued.
- **Community Support and Stock Recommendations:** (15%) Many users are sharing their stock picks and strategies, with QURE being a frequent recommendation.
  
**Most Critical Themes**
- **Uncertainty around Clinical Trial Data:** (10%)  Some posts express concerns about the validity of the clinical trial data and the potential for negative outcomes.
- **Market Volatility and General Market Conditions:** (10%)  Some posts mention the overall market conditions and the potential for volatility, which could impact QURE's price.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | XX% |
| TikTok  | X        | X%  | X       | X%  | X        | X%  |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | XX% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$qure/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$qure/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.593%  
**1 Month**: XXXXX% +0.05%  
**1-Year High**: XXXX% on 2025-09-26  
**1-Year Low**: XXXXXX% on 2025-09-14  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$qure/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$qure/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXXXX% on 2025-10-09  
**1-Year Low**: XXXXXXX% on 2025-09-19  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$qure/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$qure/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX -$2.90%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-10-09  
**1-Year Low**: $XXXXXXXXXXX on 2025-09-19  

**Top assets mentioned**
In the posts about uniQure N.V. in the last XX hours

[Lithium Americas Corp. Common Shares (LAC)](/topic/$lac)
[Tesla, Inc. (TSLA)](/topic/tesla)
[Tesla, Inc. (TSLA)](/topic/$tsla)
[Quantum Computing Inc. Common (QUBT)](/topic/$qubt)
[Regencell Bioscience Holdings Limited Ordinary Shares (RGC)](/topic/$rgc)
[Rigetti Computing, Inc. Common Stock (RGTI)](/topic/$rgti)
[Oklo Inc. (OKLO)](/topic/$oklo)
[Advanced Micro Devices (AMD)](/topic/advanced-micro-devices)
[Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax)

**Top topics mentioned**
In the posts about uniQure N.V. in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [$clpt](/topic/$clpt), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$abvx](/topic/$abvx), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$lac](/topic/$lac), [stocks](/topic/stocks), [$omer](/topic/$omer), [tesla](/topic/tesla), [$nktr](/topic/$nktr), [$tsla](/topic/$tsla), [$sava](/topic/$sava), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [$qubt](/topic/$qubt), [$rgc](/topic/$rgc), [$rgti](/topic/$rgti), [$oklo](/topic/$oklo), [coins defi](/topic/coins-defi), [advanced micro devices](/topic/advanced-micro-devices), [investment](/topic/investment), [coins base ecosystem](/topic/coins-base-ecosystem), [$prax](/topic/$prax), [$bmrn](/topic/$bmrn), [$ntla](/topic/$ntla), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$sgmo](/topic/$sgmo), [$aqms](/topic/$aqms), [$dgnx](/topic/$dgnx), [upside](/topic/upside), [$amzn](/topic/$amzn), [$googl](/topic/$googl), [$cytk](/topic/$cytk), [money](/topic/money), [$asts](/topic/$asts), [$xbi](/topic/$xbi), [$qbts](/topic/$qbts), [$cdtx](/topic/$cdtx), [$gnpx](/topic/$gnpx), [$arwr](/topic/$arwr), [$insm](/topic/$insm), [$crwv](/topic/$crwv), [$mltx](/topic/$mltx), [$artv](/topic/$artv), [$crsp](/topic/$crsp), [$sdot](/topic/$sdot), [$intc](/topic/$intc), [$pali](/topic/$pali), [stocks industrials](/topic/stocks-industrials), [$nvda](/topic/$nvda), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$imrx](/topic/$imrx), [$itp](/topic/$itp), [$onds](/topic/$onds), [$nbis](/topic/$nbis), [$ionq](/topic/$ionq), [coins dao](/topic/coins-dao), [stocks financial services](/topic/stocks-financial-services), [$apge](/topic/$apge), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$pepg](/topic/$pepg), [$spy](/topic/$spy), [$beam](/topic/$beam), [$sprb](/topic/$sprb), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$regn](/topic/$regn), [$ibg](/topic/$ibg), [$slno](/topic/$slno), [$elbm](/topic/$elbm), [bitfarms](/topic/bitfarms), [$rani](/topic/$rani), [vix](/topic/vix), [$oscr](/topic/$oscr), [$rna](/topic/$rna), [telegram](/topic/telegram), [$apld](/topic/$apld), [$srpt](/topic/$srpt), [victor](/topic/victor), [coins bsc](/topic/coins-bsc), [positions](/topic/positions), [acquisition](/topic/acquisition), [donald trump](/topic/donald-trump), [$aapl](/topic/$aapl), [$wolf](/topic/$wolf), [stocks communication services](/topic/stocks-communication-services), [$85114b](/topic/$85114b), [$ions](/topic/$ions), [botswana](/topic/botswana), [$kzr](/topic/$kzr), [$coot](/topic/$coot), [$rckt](/topic/$rckt), [momentum](/topic/momentum), [iren limited](/topic/iren-limited), [hc](/topic/hc), [$crnx](/topic/$crnx), [dp](/topic/dp), [$akro](/topic/$akro), [jordan](/topic/jordan), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$uuuu](/topic/$uuuu)

### Top Social Posts [#](/topic/$qure/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Bank of America AGIO US: Agios Pharmaceuticals - Positive CHMP opinion bolsters confidence in global approvals - BUY Full report in Telegram (in bio)πŸ‘† $AGIO $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE"  
[X Link](https://x.com/Biobeats99/status/1979607196645384305) [@Biobeats99](/creator/x/Biobeats99) 2025-10-18T17:55Z XXX followers, XXX engagements


"What does this mean for $QURE holders Essentially this creates ENORMOUS incentive for $QURE holders to realize capital gains in the SAME tax year they purchased and likely REBUY on Jan X. Speculation but maybe this was a cause of the Sep 29-Oct X selling pressure"  
[X Link](https://x.com/johnkmason/status/1979599386507108588) [@johnkmason](/creator/x/johnkmason) 2025-10-18T17:24Z XXX followers, XXX engagements


"Welcome to our stock investment discussion group. Here we: Grow together with a group of dedicated investors Let's seize opportunities through communication and move forward steadily. Join the discussion now: $ASTS $BITF $APLD $QURE $NUAI $APGE"  
[X Link](https://x.com/HenryHarris666/status/1979559447455498673) [@HenryHarris666](/creator/x/HenryHarris666) 2025-10-18T14:45Z 1915 followers, XXX engagements


"🧬 Biopharma Weekly Recap πŸ“ This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out πŸ‘‡ @ericjackson πŸ’Š Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside"  
[X Link](https://x.com/BiopharmIQ/status/1979539567184347239) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-18T13:26Z 27.4K followers, 9909 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

uniQure N.V. Graphic uniQure N.V. (QURE)

uniQure N.V. (QURE) sees a surge in social media engagement, driven by positive clinical trial results and analyst recommendations. The stock is up XXX% in the last XX days.

About uniQure N.V.

uniQure N.V. (QURE) is a biotechnology company focused on gene therapy for the treatment of severe diseases.
uniQure N.V. uses the ticker $QURE for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • uniQure N.V. (QURE) social dominance hit XXXXX which is XXX% higher than it's daily average.
  • uniQure N.V. (QURE) social dominance is up XXXXXXXX% from the previous week.
  • uniQure N.V. (QURE) galaxy scoreβ„’ is up XXXXX% from the previous week.

Price: $XX #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The price action is likely driven by a combination of positive sentiment from recent clinical trial data, analyst recommendations, and overall market enthusiasm for gene therapy stocks. The stock has seen a significant increase over the last XX days, and the recent public offering and the potential for future partnerships are also contributing factors.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% XXXXXX%

1-Year High: $XXXXX on 2025-10-09
1-Year Low: $XXXX on 2024-11-04

AltRank: undefined #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
uniQure N.V. (QURE) is currently AltRank #undefined based on combined combined social and market metrics Daily Average: undefined
1 Week: XXX +251
1-Year High: undefined on 2025-10-18
1-Year Low: undefined on 2025-10-18

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +17
1-Year High: XX on 2025-10-12
1-Year Low: XX on 2025-10-16

Engagements: XXXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXXXX +1,209%
1-Year High: XXXXXXXXX on 2025-09-24
1-Year Low: XXXXX on 2025-07-13

Social Network X TikTok YouTube
Engagements XXXXXX X X

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX +229%
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-09-14

Social Network X TikTok YouTube
Mentions XXX X X

Creators: XXX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning uniQure N.V. (QURE) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XX
1 Month: XXX +256%
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-09-14

The most influential creators that mention uniQure N.V. in the last XX hours

Creator Rank Followers Posts Engagements
@BiopharmIQ X XXXXXX X XXXXX
@seedy19tron X XXXXX X XXXXX
@NoseRubInvest X XXXXX X XXXXX
@crux_capital_ X XXXXX X XXXXX
@pawcio2009 X XXXXXX X XXXXX
@HenryHarris666 X XXXXX X XXX
@mike98572986 X XXX X XXX
@DesertDweller93 X XXXXX XX XXX
@Biobeats99 X XXX XX XXX
@BostonDrei XX XXXXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +13%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-15

Most Supportive Themes

  • Positive Sentiment and Price Momentum: (45%) Many posts express positive sentiment towards uniQure N.V. (QURE), with users highlighting recent price gains and potential for future growth.
  • Analyst Recommendations and Price Targets: (20%) Several posts reference analyst ratings and price targets, with some suggesting that the current valuation is undervalued.
  • Community Support and Stock Recommendations: (15%) Many users are sharing their stock picks and strategies, with QURE being a frequent recommendation.

Most Critical Themes

  • Uncertainty around Clinical Trial Data: (10%) Some posts express concerns about the validity of the clinical trial data and the potential for negative outcomes.
  • Market Volatility and General Market Conditions: (10%) Some posts mention the overall market conditions and the potential for volatility, which could impact QURE's price.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXXX XX% XXXXX XX%
TikTok X X% X X% X X%
YouTube X X% X X% X X%
Total XXXXX XX% XXXXXX XX% XXXXX XX%

Social Dominance: XXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.593%
1 Month: XXXXX% +0.05%
1-Year High: XXXX% on 2025-09-26
1-Year Low: XXXXXX% on 2025-09-14

Market Dominance: XXXXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-10-09
1-Year Low: XXXXXXX% on 2025-09-19

Market Cap: $XXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$2.90%
1-Year High: $XXXXXXXXXXXXX on 2025-10-09
1-Year Low: $XXXXXXXXXXX on 2025-09-19

Top assets mentioned In the posts about uniQure N.V. in the last XX hours

Lithium Americas Corp. Common Shares (LAC) Tesla, Inc. (TSLA) Tesla, Inc. (TSLA) Quantum Computing Inc. Common (QUBT) Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Rigetti Computing, Inc. Common Stock (RGTI) Oklo Inc. (OKLO) Advanced Micro Devices (AMD) Praxis Precision Medicines, Inc. Common Stock (PRAX)

Top topics mentioned In the posts about uniQure N.V. in the last XX hours

stocks healthcare, stocks technology, $clpt, stocks bitcoin treasuries, $abvx, stocks consumer cyclical, $lac, stocks, $omer, tesla, $nktr, $tsla, $sava, stocks bitcoin miners, $qubt, $rgc, $rgti, $oklo, coins defi, advanced micro devices, investment, coins base ecosystem, $prax, $bmrn, $ntla, sarepta therapeutics inc, $sgmo, $aqms, $dgnx, upside, $amzn, $googl, $cytk, money, $asts, $xbi, $qbts, $cdtx, $gnpx, $arwr, $insm, $crwv, $mltx, $artv, $crsp, $sdot, $intc, $pali, stocks industrials, $nvda, stocks crypto treasuries, $imrx, $itp, $onds, $nbis, $ionq, coins dao, stocks financial services, $apge, stocks consumer defensive, $pepg, $spy, $beam, $sprb, regeneron pharmaceuticals inc, $regn, $ibg, $slno, $elbm, bitfarms, $rani, vix, $oscr, $rna, telegram, $apld, $srpt, victor, coins bsc, positions, acquisition, donald trump, $aapl, $wolf, stocks communication services, $85114b, $ions, botswana, $kzr, $coot, $rckt, momentum, iren limited, hc, $crnx, dp, $akro, jordan, coins solana ecosystem, $uuuu

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Bank of America AGIO US: Agios Pharmaceuticals - Positive CHMP opinion bolsters confidence in global approvals - BUY Full report in Telegram (in bio)πŸ‘† $AGIO $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE"
X Link @Biobeats99 2025-10-18T17:55Z XXX followers, XXX engagements

"What does this mean for $QURE holders Essentially this creates ENORMOUS incentive for $QURE holders to realize capital gains in the SAME tax year they purchased and likely REBUY on Jan X. Speculation but maybe this was a cause of the Sep 29-Oct X selling pressure"
X Link @johnkmason 2025-10-18T17:24Z XXX followers, XXX engagements

"Welcome to our stock investment discussion group. Here we: Grow together with a group of dedicated investors Let's seize opportunities through communication and move forward steadily. Join the discussion now: $ASTS $BITF $APLD $QURE $NUAI $APGE"
X Link @HenryHarris666 2025-10-18T14:45Z 1915 followers, XXX engagements

"🧬 Biopharma Weekly Recap πŸ“ This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out πŸ‘‡ @ericjackson πŸ’Š Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside"
X Link @BiopharmIQ 2025-10-18T13:26Z 27.4K followers, 9909 engagements

uniQure N.V. (QURE)
/topic/$qure